Transcode Therapeutics Inc
NASDAQ:RNAZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Transcode Therapeutics Inc
NASDAQ:RNAZ
|
US |
|
U
|
US GoldMining Inc
NASDAQ:USGO
|
CA |
|
P
|
Procter & Gamble Co
BMV:PG
|
US |
|
M
|
MetroGAS SA
BCBA:METR
|
AR |
|
N
|
Nordic Nanovector ASA
F:8NN
|
NO |
|
IHI Corp
TSE:7013
|
JP |
|
Regis Corp
NASDAQ:RGS
|
US |
|
A
|
Avi Ltd
JSE:AVI
|
ZA |
|
M
|
Mega First Corporation Bhd
KLSE:MFCB
|
MY |
|
Altus Group Ltd
TSX:AIF
|
CA |
|
Kurabo Industries Ltd
TSE:3106
|
JP |
|
C
|
Challenger Exploration Ltd
ASX:CEL
|
AU |
|
HeadHunter Group PLC
MOEX:HHRU
|
CY |
|
Cal-Maine Foods Inc
NASDAQ:CALM
|
US |
|
FormFactor Inc
NASDAQ:FORM
|
US |
|
T
|
TRF Ltd
NSE:TRF
|
IN |
|
Anglo American PLC
LSE:AAL
|
UK |
|
Qrf NV
XBRU:QRF
|
BE |
|
Tesla Inc
NASDAQ:TSLA
|
US |
Bankruptcy Probability
Transcode Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Transcode Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Transcode Therapeutics Inc
NASDAQ:RNAZ
|
5.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
150.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Transcode Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Transcode Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
